CS251091A3 - Tricyclic heterocyclic derivatives, process of their preparation and pharmaceuticals containing them - Google Patents
Tricyclic heterocyclic derivatives, process of their preparation and pharmaceuticals containing them Download PDFInfo
- Publication number
- CS251091A3 CS251091A3 CS912510A CS251091A CS251091A3 CS 251091 A3 CS251091 A3 CS 251091A3 CS 912510 A CS912510 A CS 912510A CS 251091 A CS251091 A CS 251091A CS 251091 A3 CS251091 A3 CS 251091A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- group
- formula
- hydroxy
- carbon atoms
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909018044A GB9018044D0 (en) | 1990-08-16 | 1990-08-16 | Tricyclic heterocyclic derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CS251091A3 true CS251091A3 (en) | 1992-03-18 |
Family
ID=10680792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS912510A CS251091A3 (en) | 1990-08-16 | 1991-08-14 | Tricyclic heterocyclic derivatives, process of their preparation and pharmaceuticals containing them |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0471516A1 (fi) |
JP (1) | JPH04257563A (fi) |
KR (1) | KR920004352A (fi) |
AU (1) | AU8142291A (fi) |
CA (1) | CA2048298A1 (fi) |
CS (1) | CS251091A3 (fi) |
FI (1) | FI913893A (fi) |
GB (2) | GB9018044D0 (fi) |
HU (1) | HUT58293A (fi) |
IE (1) | IE912616A1 (fi) |
IL (1) | IL99075A0 (fi) |
NO (1) | NO913187L (fi) |
PT (1) | PT98680A (fi) |
ZA (1) | ZA915937B (fi) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7145396A (en) * | 1995-10-04 | 1997-04-28 | Eisai Co. Ltd. | Acridone compounds |
US6063921A (en) | 1997-11-20 | 2000-05-16 | Pharm-Eco Laboratories, Inc. | Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines |
US7179912B2 (en) | 2000-09-01 | 2007-02-20 | Icos Corporation | Materials and methods to potentiate cancer treatment |
EP1660473A2 (en) * | 2003-03-24 | 2006-05-31 | Luitpold Pharmaceuticals, Inc. | Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
PL2130817T3 (pl) * | 2008-06-05 | 2016-06-30 | Agfa Graphics Nv | Polimeryzowalne fotoinicjatory typu ii oraz kompozycje utwardzalne |
US11866412B1 (en) | 2023-03-03 | 2024-01-09 | King Faisal University | Acridin-9-one compounds as antibacterial agents |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1585099A (fi) * | 1967-07-13 | 1970-01-09 | ||
DE2759468A1 (de) * | 1977-08-29 | 1979-06-07 | Sterling Drug Inc | Acridinonverbindungen und ihre herstellung |
-
1990
- 1990-08-16 GB GB909018044A patent/GB9018044D0/en active Pending
-
1991
- 1991-07-24 IE IE261691A patent/IE912616A1/en unknown
- 1991-07-26 HU HU912511A patent/HUT58293A/hu unknown
- 1991-07-29 ZA ZA915937A patent/ZA915937B/xx unknown
- 1991-07-29 AU AU81422/91A patent/AU8142291A/en not_active Abandoned
- 1991-08-01 CA CA002048298A patent/CA2048298A1/en not_active Abandoned
- 1991-08-02 GB GB919116779A patent/GB9116779D0/en active Pending
- 1991-08-04 IL IL99075A patent/IL99075A0/xx unknown
- 1991-08-09 EP EP91307341A patent/EP0471516A1/en not_active Withdrawn
- 1991-08-14 KR KR1019910014211A patent/KR920004352A/ko not_active Application Discontinuation
- 1991-08-14 PT PT98680A patent/PT98680A/pt not_active Application Discontinuation
- 1991-08-14 CS CS912510A patent/CS251091A3/cs unknown
- 1991-08-15 JP JP3205027A patent/JPH04257563A/ja active Pending
- 1991-08-15 NO NO91913187A patent/NO913187L/no unknown
- 1991-08-16 FI FI913893A patent/FI913893A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IE912616A1 (en) | 1992-02-26 |
ZA915937B (en) | 1992-04-29 |
KR920004352A (ko) | 1992-03-27 |
PT98680A (pt) | 1992-08-31 |
FI913893A (fi) | 1992-02-17 |
JPH04257563A (ja) | 1992-09-11 |
NO913187L (no) | 1992-02-17 |
GB9018044D0 (en) | 1990-10-03 |
HU912511D0 (en) | 1992-01-28 |
CA2048298A1 (en) | 1992-02-17 |
HUT58293A (en) | 1992-02-28 |
AU8142291A (en) | 1992-02-20 |
NO913187D0 (no) | 1991-08-15 |
IL99075A0 (en) | 1992-07-15 |
GB9116779D0 (en) | 1991-09-18 |
EP0471516A1 (en) | 1992-02-19 |
FI913893A0 (fi) | 1991-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6395733B1 (en) | Heterocyclic ring-fused pyrimidine derivatives | |
EP0831829B1 (en) | Heterocyclic ring-fused pyrimidine derivatives | |
JP3457737B2 (ja) | 三環式誘導体、その製造方法及び温血動物において抗癌作用を発生させるために使用する薬剤学的組成物 | |
KR910001136B1 (ko) | 축합 이미다조피리딘 유도체의 제조방법 | |
AU651353B2 (en) | Pyrazolopyridine compound and processes for preparation thereof | |
AU668694B2 (en) | Saccharin derivative proteolytic enzyme inhibitors | |
EA001595B1 (ru) | Необратимые ингибиторы тирозинкиназ | |
HU217623B (hu) | Eljárás kondenzált tieno- és pirrolo [3,2-c]piridin-2-karbonsav-származékok valamint e vegyületeket tartalmazó gyógyászati készítmények előállítására | |
EP0381132B1 (en) | Imidazopyridazines, their production and use | |
CS186391A3 (en) | Pharmaceuticals | |
CZ299794B6 (cs) | Analogy kamptothecinu, zpusob jejich prípravy a farmaceutické prostredky obsahující tyto analogy | |
PL119520B1 (en) | Process for preparing novel,condensed pyrimidine derivatives pirimidina | |
EP0434999B1 (en) | Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same | |
CS251091A3 (en) | Tricyclic heterocyclic derivatives, process of their preparation and pharmaceuticals containing them | |
AU598878B2 (en) | Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component | |
EP0556585A2 (en) | Condensed camptothecin derivatives their production and use as antitumor agents | |
EP0339976B1 (en) | Anti-tumour agents | |
US6288073B1 (en) | Acronycine derivatives, preparation method and pharmaceutical compositions | |
EP0882723A1 (en) | Thioxanthenone antitumor agents | |
ES2200829T3 (es) | Analogos opticamente puros de la campotecina. | |
NZ194228A (en) | 2-(1,4-diazacycloalk-1-yl)-4-(morpholino or thiomorpholino)-8-substituted pyrimido(4,5-b)pyrimidines | |
EP1336608A1 (en) | Dibenzosberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives | |
EP0639183B1 (en) | Nitrogen oxides of aza- and diaza-anthracenedione derivatives, their preparation and their use as antitumor agents | |
FI79111C (fi) | Foerfarande foer framstaellning av terapeutiskt vaerdefulla 1,3-dihydro-6-aminometyl-7-hydroxi-furo- (3,4-c)-pyridinderivat. | |
JP3115575B2 (ja) | イミダゾピリダジン誘導体、その用途及び製造法 |